{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:33:58Z","timestamp":1793025238952,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270941"],"award-info":[{"award-number":["81270941"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471052"],"award-info":[{"award-number":["81471052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012164","name":"National High-tech Research and Development Program","doi-asserted-by":"publisher","award":["2011AA020101"],"award-info":[{"award-number":["2011AA020101"]}],"id":[{"id":"10.13039\/501100012164","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["SQ2017YFSF090065"],"award-info":[{"award-number":["SQ2017YFSF090065"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["81900730"],"award-info":[{"award-number":["81900730"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic cardiomyopathy (DCM) is a cardiac complication of long-term uncontrolled diabetes and is characterized by myocardial fibrosis and abnormal cardiac function. Mesenchymal stem cells (MSCs) are multipotent cells with immunoregulatory and secretory functions in diabetes and heart diseases. However, very few studies have focused on the effect and the underlying mechanism of MSCs on myocardial fibrosis in DCM. Therefore, we aimed to explore the therapeutic potential of MSCs in myocardial fibrosis and its underlying mechanism in vivo and in vitro.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A DCM rat model was induced using a high-fat diet (HFD) combined with a low-dose streptozotocin (STZ) injection. After four infusions of MSCs, rat serum and heart tissues were collected, and the levels of blood glucose and lipid, cardiac structure, and function, and the degree of myocardial fibrosis including the expression levels of pro-fibrotic factor and collagen were analyzed using biochemical methods, echocardiography, histopathology, polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay (ELISA). We infused prostaglandin E2 (PGE2)-deficient MSCs to DCM rats in vivo and established a system mimicking diabetic myocardial fibrosis in vitro by inducing cardiac fibroblasts with high glucose (HG) and coculturing them with MSCs or PGE2-deficient MSCs to further explore the underlying mechanism of amelioration of myocardial fibrosis by MSCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Metabolic abnormalities, myocardial fibrosis, and cardiac dysfunction in DCM rats were significantly ameliorated after treatment with MSCs. Moreover, the levels of TGF-\u03b2, collagen I, collagen III, and collagen accumulation were markedly decreased after MSC infusion compared to those in DCM hearts. However, PGE2-deficient MSCs had decreased ability to alleviate cardiac fibrosis and dysfunction. In addition, in vitro study revealed that the concentration of PGE2 in the MSC group was enhanced, while the proliferation and collagen secretion of cardiac fibroblasts were reduced after MSC treatment. However, MSCs had little effect on alleviating fibrosis when the fibroblasts were pretreated with cyclooxygenase-2 (COX-2) inhibitors, which also inhibited PGE2 secretion. This phenomenon could be reversed by adding PGE2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results indicated that MSC infusion could ameliorate cardiac fibrosis and dysfunction in DCM rats. The underlying mechanisms might involve the function of PGE2 secreted by MSCs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-01633-7","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T09:02:47Z","timestamp":1584435767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2"],"prefix":"10.1186","volume":"11","author":[{"given":"Liyuan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"issue":"3","key":"1633_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2337\/db11-0477","volume":"61","author":"M Rajesh","year":"2012","unstructured":"Rajesh M, Batkai S, Kechrid M, Mukhopadhyay P, Lee WS, Horvath B, Holovac E, Cinar R, Liaudet L, Mackie K, et al. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes. 2012;61(3):716\u201327.","journal-title":"Diabetes"},{"issue":"25","key":"1633_CR2","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","volume":"56","author":"M Rajesh","year":"2010","unstructured":"Rajesh M, Mukhopadhyay P, Batkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horvath B, Mukhopadhyay B, Becker L, et al. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol. 2010;56(25):2115\u201325.","journal-title":"J Am Coll Cardiol"},{"issue":"5 Pt B","key":"1633_CR3","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.bbadis.2017.10.035","volume":"1864","author":"U Varma","year":"2018","unstructured":"Varma U, Koutsifeli P, Benson VL, Mellor KM, Delbridge LMD. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights. Biochim Biophys Acta Mol Basis Dis. 2018;1864(5 Pt B):1949\u201359.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1633_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","volume":"133","author":"Y Yue","year":"2017","unstructured":"Yue Y, Meng K, Pu Y, Zhang X. Transforming growth factor beta (TGF-beta) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract. 2017;133:124\u201330.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1633_CR5","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2337\/db09-1456","volume":"59","author":"K Huynh","year":"2010","unstructured":"Huynh K, McMullen JR, Julius TL, Tan JW, Love JE, Cemerlang N, Kiriazis H, Du XJ, Ritchie RH. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes. 2010;59(6):1512\u201320.","journal-title":"Diabetes"},{"issue":"4","key":"1633_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jacc.2005.09.050","volume":"47","author":"J Asbun","year":"2006","unstructured":"Asbun J, Villarreal FJ. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol. 2006;47(4):693\u2013700.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1633_CR7","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.116.305381","volume":"116","author":"A Leask","year":"2015","unstructured":"Leask A. Getting to the heart of the matter: new insights into cardiac fibrosis. Circ Res. 2015;116(7):1269\u201376.","journal-title":"Circ Res"},{"issue":"1","key":"1633_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","volume":"10","author":"KT Weber","year":"2013","unstructured":"Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol. 2013;10(1):15\u201326.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"1633_CR9","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1152\/physrev.00019.2015","volume":"96","author":"S Golpanian","year":"2016","unstructured":"Golpanian S, Wolf A, Hatzistergos KE, Hare JM. Rebuilding the damaged heart: Mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol Rev. 2016;96(3):1127\u201368.","journal-title":"Physiol Rev"},{"issue":"1","key":"1633_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.arr.2010.08.005","volume":"10","author":"YL Si","year":"2011","unstructured":"Si YL, Zhao YL, Hao HJ, Fu XB, Han WD. MSCs: biological characteristics, clinical applications and their outstanding concerns. Ageing Res Rev. 2011;10(1):93\u2013103.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"1633_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1161\/CIRCRESAHA.116.309717","volume":"120","author":"J Butler","year":"2017","unstructured":"Butler J, Epstein SE, Greene SJ, Quyyumi AA, Sikora S, Kim RJ, Anderson AS, Wilcox JE, Tankovich NI, Lipinski MJ, et al. Intravenous allogeneic mesenchymal stem cells for nonischemic cardiomyopathy: safety and efficacy results of a phase II-A randomized trial. Circ Res. 2017;120(2):332\u201340.","journal-title":"Circ Res"},{"issue":"10","key":"1633_CR12","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/stem.1191","volume":"30","author":"JH Ylostalo","year":"2012","unstructured":"Ylostalo JH, Bartosh TJ, Coble K, Prockop DJ. Human mesenchymal stem\/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells. 2012;30(10):2283\u201396.","journal-title":"Stem Cells"},{"issue":"3","key":"1633_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/stem.2238","volume":"34","author":"Z Xie","year":"2016","unstructured":"Xie Z, Hao H, Tong C, Cheng Y, Liu J, Pang Y, Si Y, Guo Y, Zang L, Mu Y, et al. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats. Stem Cells. 2016;34(3):627\u201339.","journal-title":"Stem Cells"},{"issue":"24","key":"1633_CR14","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1089\/scd.2017.0119","volume":"26","author":"J Zhang","year":"2017","unstructured":"Zhang J, Deng Z, Jin L, Yang C, Liu J, Song H, Han W, Si Y. Spleen-derived anti-inflammatory cytokine IL-10 stimulated by adipose tissue-derived stem cells protects against type 2 diabetes. Stem Cells Dev. 2017;26(24):1749\u201358.","journal-title":"Stem Cells Dev"},{"key":"1633_CR15","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.1038\/srep08713","volume":"5","author":"LH Dong","year":"2015","unstructured":"Dong LH, Jiang YY, Liu YJ, Cui S, Xia CC, Qu C, Jiang X, Qu YQ, Chang PY, Liu F. The anti-fibrotic effects of mesenchymal stem cells on irradiated lungs via stimulating endogenous secretion of HGF and PGE2. Sci Rep. 2015;5:8713.","journal-title":"Sci Rep"},{"issue":"2","key":"1633_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ki.2012.125","volume":"82","author":"P Boor","year":"2012","unstructured":"Boor P. EP4: a new piece in the fibrotic puzzle. Kidney Int. 2012;82(2):132\u20135.","journal-title":"Kidney Int"},{"issue":"6","key":"1633_CR17","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1172\/JCI38369","volume":"120","author":"KA Bauman","year":"2010","unstructured":"Bauman KA, Wettlaufer SH, Okunishi K, Vannella KM, Stoolman JS, Huang SK, Courey AJ, White ES, Hogaboam CM, Simon RH, et al. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. J Clin Invest. 2010;120(6):1950\u201360.","journal-title":"J Clin Invest"},{"issue":"9","key":"1633_CR18","doi-asserted-by":"publisher","first-page":"e108105","DOI":"10.1371\/journal.pone.0108105","volume":"9","author":"X Tian","year":"2014","unstructured":"Tian X, Fan J, Yu M, Zhao Y, Fang Y, Bai S, Hou W, Tong H. Adipose stem cells promote smooth muscle cells to secrete elastin in rat abdominal aortic aneurysm. PLoS One. 2014;9(9):e108105.","journal-title":"PLoS One"},{"key":"1633_CR19","doi-asserted-by":"publisher","first-page":"204173141559235","DOI":"10.1177\/2041731415592356","volume":"6","author":"OG Davies","year":"2015","unstructured":"Davies OG, Cooper PR, Shelton RM, Smith AJ, Scheven BA. Isolation of adipose and bone marrow mesenchymal stem cells using CD29 and CD90 modifies their capacity for osteogenic and adipogenic differentiation. J Tissue Eng. 2015;6:2041731415592356.","journal-title":"J Tissue Eng"},{"issue":"5","key":"1633_CR20","doi-asserted-by":"publisher","first-page":"e004567","DOI":"10.1161\/CIRCEP.116.004567","volume":"10","author":"N Salvarani","year":"2017","unstructured":"Salvarani N, Maguy A, De Simone SA, Miragoli M, Jousset F, Rohr S. TGF-beta1 (transforming growth factor-beta1) plays a pivotal role in cardiac Myofibroblast Arrhythmogenicity. Circ Arrhythm Electrophysiol. 2017;10(5):e004567.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"1633_CR21","first-page":"2709","volume":"42","author":"P Duan","year":"2018","unstructured":"Duan P, Wang J, Li Y, Wei S, Su F, Zhang S, Duan Y, Wang L, Zhu Q. Opening of mitoKATP improves cardiac function and inhibits apoptosis via the AKT-Foxo1 signaling pathway in diabetic cardiomyopathy. Int J Mol Med. 2018;42(5):2709\u201319.","journal-title":"Int J Mol Med"},{"issue":"9","key":"1633_CR22","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.amjmed.2008.03.046","volume":"121","author":"A Aneja","year":"2008","unstructured":"Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med. 2008;121(9):748\u201357.","journal-title":"Am J Med"},{"issue":"4","key":"1633_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4070\/kcj.2015.45.4.266","volume":"45","author":"S Yilmaz","year":"2015","unstructured":"Yilmaz S, Canpolat U, Aydogdu S, Abboud HE. Diabetic cardiomyopathy; summary of 41 years. Korean Circ J. 2015;45(4):266\u201372.","journal-title":"Korean Circ J"},{"issue":"4","key":"1633_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57(4):660\u201371.","journal-title":"Diabetologia"},{"issue":"12","key":"1633_CR25","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.cardfail.2010.07.249","volume":"16","author":"S Murarka","year":"2010","unstructured":"Murarka S, Movahed MR. Diabetic cardiomyopathy. J Card Fail. 2010;16(12):971\u20139.","journal-title":"J Card Fail"},{"issue":"11","key":"1633_CR26","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1002\/stem.169","volume":"27","author":"C Mias","year":"2009","unstructured":"Mias C, Lairez O, Trouche E, Roncalli J, Calise D, Seguelas MH, Ordener C, Piercecchi-Marti MD, Auge N, Salvayre AN, et al. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells. 2009;27(11):2734\u201343.","journal-title":"Stem Cells"},{"issue":"12","key":"1633_CR27","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1096\/fj.201600433R","volume":"30","author":"D Haldar","year":"2016","unstructured":"Haldar D, Henderson NC, Hirschfield G, Newsome PN. Mesenchymal stromal cells and liver fibrosis: a complicated relationship. FASEB J. 2016;30(12):3905\u201328.","journal-title":"FASEB J"},{"issue":"6","key":"1633_CR28","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2337\/db11-1141","volume":"61","author":"Y Si","year":"2012","unstructured":"Si Y, Zhao Y, Hao H, Liu J, Guo Y, Mu Y, Shen J, Cheng Y, Fu X, Han W. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity. Diabetes. 2012;61(6):1616\u201325.","journal-title":"Diabetes"},{"issue":"10","key":"1633_CR29","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110(10):3499\u2013506.","journal-title":"Blood"},{"issue":"4","key":"1633_CR30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","volume":"13","author":"ME Bernardo","year":"2013","unstructured":"Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013;13(4):392\u2013402.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"1633_CR31","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s10620-015-3552-9","volume":"60","author":"AC Baird","year":"2015","unstructured":"Baird AC, Lloyd F, Lawrance IC. Prostaglandin E(2) and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function. Dig Dis Sci. 2015;60(6):1603\u201316.","journal-title":"Dig Dis Sci"},{"key":"1633_CR32","first-page":"463524","volume":"2014","author":"JY Byun","year":"2014","unstructured":"Byun JY, Youn YS, Lee YJ, Choi YH, Woo SY, Kang JL. Interaction of apoptotic cells with macrophages upregulates COX-2\/PGE2 and HGF expression via a positive feedback loop. Mediat Inflamm. 2014;2014:463524.","journal-title":"Mediat Inflamm"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01633-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-020-01633-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01633-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T20:34:30Z","timestamp":1615926870000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01633-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1633"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01633-7","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"21 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Procedures involving animals and their care were conducted in conformity with the revised guidelines (Animals Act 1986) and were approved by the Animal Care and Use Committee of the Chinese PLA General Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}